Patents by Inventor Daniel M. HALLOW

Daniel M. HALLOW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHS OF D9-THC NAPHTHOYLESTER
    Publication number: 20240109857
    Abstract: The present disclosure relates to polymorphs of D9-THC-naphthoylester for the preparation of D9-Tetrahydrocannabinol in high yields and high purity, methods of preparing the D9-Tetrahydrocannabinol, and compositions comprising the D9-Tetrahydrocannabinol.
    Type: Application
    Filed: October 14, 2020
    Publication date: April 4, 2024
    Inventors: Daniel M. HALLOW, MARC IULIUCCI, GNEL MKRTCHYAN, STEPHEN A.R. CARINO, FRANK JOSEPH TARCZYNSKI, JOANNA ANGELIKA BIS
  • PROCESSES FOR THE PREPARATION OF HALOGENATED DIHYDROXYBENZENE COMPOUNDS
    Publication number: 20230183157
    Abstract: The present disclosure relates to the preparation of halogenated dihydroxybenzene compounds with high yield, selectivity and purity. The compounds are useful, among other things, in the synthesis of cannabinoids and cannabinoid-type compounds.
    Type: Application
    Filed: May 29, 2020
    Publication date: June 15, 2023
    Inventors: Daniel M. HALLOW, Mark C. DOBISH, Gnel MKRTCHYAN, Richard WOOD, Ramanaiah C. KANAMARLAPUDI, Achintya SUJAN, Amber BURCH
  • CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES
    Publication number: 20220218651
    Abstract: The present disclosure relates to the preparation of a highly pure cannabidiol compound by a novel synthesis route. The cannabidiol compound can be prepared by an acid-catalyzed reaction of a di-halo olivetol with menthadienol, followed by two crystallization steps. The highly pure cannabidiol compound is produced in high yield, stereospecificity, or both, and shows exceedingly low levels of ?-9-tetrahydrocannabinol at the time of preparation and after storage.
    Type: Application
    Filed: September 5, 2019
    Publication date: July 14, 2022
    Inventors: Daniel M. Hallow, Jun HE, Mark C. DOBISH, Denis PETROVIC, Gnel MKRTCHYAN
  • Hepatitis C virus inhibitors
    Patent number: 10494400
    Abstract: The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: December 3, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: Scott A. Savage, Nathan R. Domagalski, Brendan Mack, Purushotham Vemishetti, Yuping Qiu, Michael Fenster, Daniel M. Hallow, Glenn Ferreira, Amanda Rogers, Sha Lou, Lindsay Hobson
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20180155393
    Abstract: The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.
    Type: Application
    Filed: June 23, 2015
    Publication date: June 7, 2018
    Inventors: Scott A. SAVAGE, Nathan R. DOMAGALSKI, Brendan MACK, Purushotham VEMISHETTI, Yuping QIU, Michael FENSTER, Daniel M. HALLOW, Glenn FERREIRA, Amanda ROGERS, Sha LOU, Lindsay HOBSON